PRESS

The talk on the town.

Our AI-driven voice analysis is making a real impact on mental healthcare.
Read what the press has to say about Kintsugi.

February 13, 2025

A Game-Changing Approach to Mental Health

In the latest episode of MedTechGurus, host Thomas Hickey sits down with Dr. Prentice Tom, Chief Medical Officer at Kintsugi, to explore how voice biomarker AI is reshaping mental health screening.

Read Full Article

January 13, 2025

Annals of Family Medicine

Evaluation of an AI-Based Voice Biomarker Tool to Detect Signals Consistent With Moderate to Severe Depression

Kintsugi’s latest peer-reviewed study, published in the Annals of Family Medicine, highlights how Voice AI can help detect depression through brief speech analysis.

Read Full Article

October 14, 2024

A.I. May Offer a Solution to America’s Gaping Mental Health Care Shortage

Grace Chang, CEO of Kintsugi, highlights that AI can help alleviate the mental health care shortage by scaling support to underserved populations and detecting signs of depression and anxiety through voice analysis, even amidst barriers like social stigma.

Read Full Article

September 25, 2024

The Long Road to Adoption: What Founders Need to Know Before Breaking into Health Tech

In an op-ed for MedCity News, Kintsugi's Chief Medical Officer, Dr. Prentice Tom, examines why many promising ideas falter, often due to a fundamental misunderstanding or underestimation of the complex, deeply rooted challenges within the healthcare industry.

Read Full Article

September 24, 2024

Kintsugi Receives Frost & Sullivan’s 2024 Enabling Technology Leadership Award

For a second time, Frost & Sullivan recognizes Kintsugi’s revolutionary impact on the mental health industry via its innovative use of voice biomarkers to help healthcare providers screen for anxiety and depression.

Read Full Article